Further studies also proved the role of FGFR2 rs2981582 as a susceptible gene for early onset of BC (Raskin et al., 2008; Siddiqui et al., 2014), even though like other low penetrance genetic variant studies, the results are not consistent among populations. The gene discussed is FGFR2; the disease is breast cancer.